Ranbaxy's troubled plants in India could see a turnaround as Sun Pharma has experience in doing so.
Rosier year-end seen for Indian pharma thanks to faster US approvals.
In the final part of a three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about American doctors' contempt for drugs exported from India and the ineptitude of the US Food and Drug Administration to stop the menace.
The changes would be immediately effective in countries like Columbia, South Korea, Peru and Panama, where FTAs are in the final stages of approval.
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
Ranbaxy Laboratories on Tuesday stood firm on its strategy of challenging patents, even as Pfizer has filed a suit against it to block the Gurgaon-based firm from going ahead with plans for Caduet.
In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.
With the bidding for the generics business of Merck set to begin from Monday, domestic pharmaceutical companies in the fray, Ranbaxy Laboratories and Dr Reddy's Laboratories, are unlikely to go for an all-out bidding war.
Elder Pharmaceuticals, one of the fast growing pharmaceutical formulation company, is getting ready to make its maiden overseas acquisition.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The guidelines lay down the processes and premises redesigning, including proper placement of equipments. Yoga institutes and gymnasiums have been asked to plan the floor area based on four metres squared per person.
Emerging markets, from South Africa to China and India, are battling to bring down healthcare costs.
As many as 15 companies across the world have lined up generic variants of Pfizer's Zoloft (Sertaline HCL), for which the exclusive six-month marketing period granted to the successful patent challenger, Teva of Israel, ends on Tuesday.
Pharmaceutical is one of the key theme for 2007 at brokerage houses such as Religare Securities, Angel Broking and Pranav Securities.
The company has received final approval from the US Food and Drug Administration for its Abacavir Sulfate Lamivudine, and Zidovudine Tablets, Lupin Ltd said in a statement.
Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia.
Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own.
Sun Pharmaceutical Industries and Lupin Ltd will soon add another generic drug each to their US product basket. The companies received approvals from the US drug regulator to market generic equivalent of Pfizer's Dilantin Kapseals and Abbot's Mavik r
The entire world is taking up the habit of 'namaste', Modi said.
The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.
'There is no shortage of any APIs (active pharmaceutical ingredients) in the country'
Dr Reddy's Laboratories has completed acquisition of betapharm, its mega overseas deal valued at 480 million (Rs 2,668 crore).\n
In another setback to India's biggest drugmaker Ranbaxy Laboratories Ltd, a court in Finland has prohibited it from marketing its generic version of Pfizer's cholesterol lowering drug Lipitor in the country.
One of the suitors says that Ranbaxy's Indian portfolio alone is worth $2 billion, or approximately Rs 11,900 crore.
Sun's acquisition of Ranbaxy would create the fifth-largest specialty generics company in the world and the largest Indian pharma company, with an estimated revenue of $4.2 billion.
Pharmaceutical firm Glenmark said on Monday it had signed a supply and marketing agreement with Aspen USA for joint manufacturing and sales of three generic products in US.
Unless you are a fresher, you should not circulate a generic CV for all openings, says Achin Bhattacharyya.
Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.
Ranbaxy is understood to have emerged as the sole Indian pharma entity to have moved into the next round of bidding for the generic business of Merck, even as compatriot Cipla claimed to be "very much in the race."
Keeping its word to make drugs affordable to consumers, the government on Thursday announced caps on margins on the sale of pharmaceutical products.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
The varsity had recently proposed adding bestselling author Chetan Bhagat's debut novel "Five Point Someone" as a "General Elective" paper for students of honours courses other than English, a choice that drew sharp reactions on the social media.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances